gptkbp:instanceOf
|
vaccine
|
gptkbp:administeredBy
|
gptkb:Injection
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
|
gptkbp:boosterRecommended
|
In outbreak situations
|
gptkbp:broadcastOn
|
Two doses
|
gptkbp:category
|
Live attenuated vaccine
|
gptkbp:commonStrainUsed
|
gptkb:Jeryl_Lynn_strain
gptkb:Leningrad-Zagreb_strain
gptkb:Rubini_strain
gptkb:Urabe_strain
|
gptkbp:contains
|
Live attenuated mumps virus
|
gptkbp:contraindication
|
gptkb:Pregnancy
Severe allergic reaction to vaccine component
Severe immunodeficiency
|
gptkbp:developedBy
|
Maurice Hilleman (Jeryl Lynn strain)
|
gptkbp:effect
|
About 88% after two doses
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mumps vaccines
|
gptkbp:includedIn
|
gptkb:MMRV_vaccine
gptkb:MMR_vaccine
|
gptkbp:introducedIn
|
1967
|
gptkbp:notRecommendedFor
|
Infants under 12 months
|
gptkbp:recommendation
|
Children
Adults without immunity
|
gptkbp:routeOfAdministration
|
Subcutaneous injection
|
gptkbp:sideEffect
|
Mild rash
Mild fever
Swelling of glands
|
gptkbp:storage
|
Refrigeration
|
gptkbp:usedFor
|
Prevention of mumps
|
gptkbp:WHOModelListOfEssentialMedicines
|
Yes
|
gptkbp:bfsParent
|
gptkb:J07AN01
|
gptkbp:bfsLayer
|
7
|